Paul R. Gugliuzza in the Media

Paul R. Gugliuzza’s faculty profile

External link Bloomberg Law logo

Bloomberg Law March 20, 2026

Manufacturing Memo Cuts Big Tech’s Sway

Professor Paul Gugliuzza considers potential consequences of the Patent Office’s decision to factor where products are made into validity reviews, a move aligned with the administration's push to reorient U.S. policies toward domestic manufacturing.  
External link Bloomberg Law logo

Bloomberg Law March 16, 2026

NJ Transit Immunity Denial Sets Stage for More Patent Suits

Professor Paul Gugliuzza suggests possible consequences of a U.S. Supreme Court ruling that the New Jersey Transit Corporation isn’t entitled to sovereign immunity in a railworker-safety patent suit.
External link Law360 logo

Law360 March 10, 2026

Justices Advised To Keep Law Clear In ‘Skinny Label’ Case

A brief co-written by Professor Paul Gugliuzza—arguing that the Hikma case complicated patent inducement jurisprudence by focusing on generic drug labels—is cited in an article offering advice to the U.S. Supreme Court on a case involving "skinny labels."
External link The New England Journal of Medicine

The New England Journal of Medicine February 7, 2026

Drug Labels as Evidence of Patent Infringement — A Troubling Legal Trend

Professor Paul R. Gugliuzza argues the Supreme Court should take the opportunity with the case Hikma Pharmaceuticals USA v. Amarin Pharma to clarify FDA-required labeling language rather than incorrectly treating it as infringement by label.
External link Logo for IPWatchdog

IP Watchdog November 13, 2025

Testing the Limits of State ‘Anti-Troll’ Laws

Professor Paul Gugliuzza pens an article examining the legal questions underlying Micron Technology v. Longhorn IPa case regarding the constitutionality of state laws designed to curb so-called "patent trolls" and bad faith patent assertions.
External link Bloomberg Law logo

Bloomberg Law November 7, 2025

Federal Circuit Gets First Crack at State ‘Patent Troll’ Laws

Professor Paul Gugliuzza analyzes possible outcomes of the US Court of Appeals for the Federal Circuit's hearing on a case challenging the constitutionality of state laws designed to limit bad-faith assertions of patent infringements.
External link Newsweek logo

Newsweek October 27, 2025

America’s Largest Lobbying Group Turns on Trump Admin Over H-1B Visas

Professor Paul Gugliuzza explains that the decision by the U.S. Chamber of Commerce to file a lawsuit against the Trump administration over a $100,000 H-1B visa fee in a federal court in Washington, D.C., stands out because of a broad trend of system abuse that makes normal cases look exceptional.
External link Patentlyo logo

PATENTLYO October 8, 2025

Have we Reached the Shenanigans Threshold?

Professor Paul Gugliuzza comments on the thin statutory basis for the broad discretionary powers of USPTO Director John Squire following his recent decision in Interactive Communications International, Inc. v. Blackhawk Network.